LT4751B - Tizoksanido ir nitazoksanido farmacinės kompozicijos - Google Patents

Tizoksanido ir nitazoksanido farmacinės kompozicijos Download PDF

Info

Publication number
LT4751B
LT4751B LT99-141A LT99141A LT4751B LT 4751 B LT4751 B LT 4751B LT 99141 A LT99141 A LT 99141A LT 4751 B LT4751 B LT 4751B
Authority
LT
Lithuania
Prior art keywords
acid
compound
formula
active
pharmaceutical composition
Prior art date
Application number
LT99-141A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT99141A (en
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Laboratories, L. C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romark Laboratories, L. C. filed Critical Romark Laboratories, L. C.
Publication of LT99141A publication Critical patent/LT99141A/xx
Publication of LT4751B publication Critical patent/LT4751B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LT99-141A 1997-05-07 1999-12-06 Tizoksanido ir nitazoksanido farmacinės kompozicijos LT4751B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (2)

Publication Number Publication Date
LT99141A LT99141A (en) 2000-08-25
LT4751B true LT4751B (lt) 2001-01-25

Family

ID=25313357

Family Applications (1)

Application Number Title Priority Date Filing Date
LT99-141A LT4751B (lt) 1997-05-07 1999-12-06 Tizoksanido ir nitazoksanido farmacinės kompozicijos

Country Status (11)

Country Link
US (2) US5968961A (sr)
AR (1) AR008355A1 (sr)
BG (1) BG65679B1 (sr)
CO (1) CO4950538A1 (sr)
CU (1) CU23318A7 (sr)
ID (1) ID24828A (sr)
LT (1) LT4751B (sr)
PL (1) PL193556B1 (sr)
RO (1) RO122247B1 (sr)
RS (2) RS50046B (sr)
ZA (1) ZA983849B (sr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
UA90864C2 (en) * 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
AU2006235490A1 (en) * 2005-04-12 2006-10-19 Romark Laboratories, L.C. Methods for treating diseases through the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
BRPI0706379A2 (pt) 2006-01-09 2011-03-22 Romark Lab Lc tratamento de hepatite viral
AU2010213678B2 (en) 2009-02-13 2015-11-26 Romark Laboratories L.C. Controlled release pharmaceutical formulations of nitazoxanide
NZ596538A (en) 2009-05-12 2014-04-30 Romark Lab Lc Haloalkyl heteroaryl benzamide compounds
CN108042535A (zh) * 2009-06-26 2018-05-18 罗马克实验室有限公司 用于治疗流感的化合物和方法
KR102037162B1 (ko) 2011-05-16 2019-10-29 로마크 레버러토리즈, 엘.씨. 바이러스병, 암 및 세포내 감염으로 인한 질병의 예방 및 치료를 위한 티아졸리드 화합물의 용도
US9498441B2 (en) * 2012-01-27 2016-11-22 Siegfried Rhein S.A. De C.V. Nitazoxadine composition and process to prepare same
US20140306689A1 (en) 2013-04-10 2014-10-16 Texas Instruments, Incorporated High resolution current pulse analog measurement
CN107105660A (zh) 2014-11-11 2017-08-29 罗马克实验室有限公司 使用替唑尼特、其类似物或盐的前药的治疗组合物和治疗方法
DK3436074T3 (da) 2016-03-31 2020-08-03 Romark Laboratories Lc Thiazolidforbindelser til behandling af virale infektioner
EP3442580B1 (en) 2016-04-11 2020-09-23 Genfit Methods of treatment for cholestatic and fibrotic diseases
US11173149B2 (en) 2017-04-18 2021-11-16 Romark Laboratories L.C. Inhibition of protein disulfide-isomerase A3
CN111971292A (zh) 2018-02-02 2020-11-20 波纹疗法公司 包含类固醇二聚体的玻璃制剂及其用途
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
WO2022020243A1 (en) 2020-07-20 2022-01-27 Romark Laboratories L.C. Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine
JP2023538136A (ja) 2020-08-24 2023-09-06 ロマーク ラボラトリーズ，リミティド カンパニー コロナウイルスに対するチアゾリドの利用
CA3233848A1 (en) 2021-10-05 2023-04-13 Sasidhar Balappa SOMAPPA An improved process for the preparation of nitazoxanide and intermediates thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950351A (en) 1973-08-08 1976-04-13 S.P.R.L. Phavic New derivatives of 2-benzamido-5-nitro thiazoles
WO1995028393A1 (en) 1994-04-13 1995-10-26 Rossignol Jean Francois Benzamide derivative, compositions containing said derivative and use thereof
US5578621A (en) 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5496809A (en) * 1989-05-10 1996-03-05 Bristol-Myers Squibb Co Stable solutions of rebeccamycin analog
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950351A (en) 1973-08-08 1976-04-13 S.P.R.L. Phavic New derivatives of 2-benzamido-5-nitro thiazoles
WO1995028393A1 (en) 1994-04-13 1995-10-26 Rossignol Jean Francois Benzamide derivative, compositions containing said derivative and use thereof
US5578621A (en) 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
CO4950538A1 (es) 2000-09-01
CU23318A7 (es) 2008-10-22
LT99141A (en) 2000-08-25
BG65679B1 (bg) 2009-06-30
ID24828A (id) 2000-08-24
AR008355A1 (es) 2000-01-19
PL193556B1 (pl) 2007-02-28
RS50046B (sr) 2008-11-28
RO122247B1 (ro) 2009-03-30
US5968961A (en) 1999-10-19
YU57199A (sr) 2002-08-12
US6117894A (en) 2000-09-12
RS49831B (sr) 2008-08-07
ZA983849B (en) 1999-08-27
RS20070379A (en) 2008-06-05

Similar Documents

Publication Publication Date Title
LT4751B (lt) Tizoksanido ir nitazoksanido farmacinės kompozicijos
US5965590A (en) Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
AU740022B2 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
US5856348A (en) Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
AU756451B2 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
CN114917209B (zh) 白皮杉醇在抗弓形虫感染的应用
MXPA99010215A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20120506